Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2020-04-28 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
审计委员会2019年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2019年度履职情况报告" (2019 Annual Performance Report) of the Audit Committee of 普莱柯生物工程股份有限公司. It details the Audit Committee's activities, including supervision and evaluation of the external audit firm, review of financial reports, internal audit work, internal control effectiveness, and communication coordination. The document is a report from the Audit Committee to the Board summarizing their work and findings for the year 2019. It is not the full audit report itself, nor is it an annual report or financial statement. It is a standalone report focused on audit committee activities and audit-related oversight, which fits the definition of an Audit Report / Information (AR) filing. The document length is 2759 characters, which is relatively short but contains substantive content about audit activities rather than just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2019
2020-04-28 Chinese
独立董事2019年度述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Directors 2019 Annual Report" and contains detailed information about the independent directors' qualifications, attendance at board and shareholder meetings, independent opinions on various company matters, oversight of related party transactions, internal control evaluations, and other governance-related activities during the 2019 fiscal year. It is a comprehensive report on the independent directors' duties and observations rather than a general annual report or financial statement. The content focuses on board/management oversight and governance rather than financial results or audit opinions. Therefore, it fits best under Board/Management Information (MANG), which covers announcements and reports related to board or senior management activities and changes. The document length is 4006 characters, which is sufficient for a detailed report but not a full annual report. No financial statements or earnings data are included, so it is not an Annual Report (10-K) or Interim Report (IR).
2020-04-28 Chinese
股东集中竞价减持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholder's concentrated bidding reduction of shares. It details the shareholder's holdings before and after the reduction, the number of shares reduced, the reduction period, and confirms that the reduction plan has been completed. There is no financial statement or report content, but rather a disclosure of shareholding changes by a significant shareholder. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2020-04-21 Chinese
股东集中竞价减持股份进展公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement regarding the progress of a shareholder's planned reduction of shares through centralized bidding. It details the shareholder's holdings before and after the reduction, the number of shares reduced, the price range, and confirms that the reduction will not affect company control or governance. There is no financial statement or detailed financial analysis present, and the document is relatively short (1867 characters). This fits the description of a Transaction in Own Shares (POS) filing, which reports on the company's or shareholders' buying or selling of shares. It is not an announcement of a report publication, nor a full financial report or management discussion. Therefore, the correct classification is POS with high confidence.
2020-04-16 Chinese
关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a change in shareholder equity, specifically a reduction in shareholding by certain shareholders. It details the shareholders involved, the number of shares reduced, and the impact on ownership percentages. The document references a "简式权益变动报告书" (Simplified Equity Change Report) and states that the shareholders involved no longer hold more than 5% of the company's shares. There is no financial data, earnings information, or management discussion. The content fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is under 5,000 characters and is a direct announcement of the shareholding change, not a report publication announcement or regulatory filing. Therefore, the correct classification is MRQ with high confidence.
2020-04-16 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding by specific shareholders in 普莱柯生物工程股份有限公司, including the number of shares sold, the method of sale (concentrated bidding on the Shanghai Stock Exchange), and the resulting shareholding percentages before and after the transactions. It also includes legal statements about compliance with securities laws and disclosure obligations. The document is focused on reporting changes in significant share ownership levels and the related disclosures required by securities regulations. There is no indication that this is an annual report, earnings release, or any other type of financial or management report. The content matches the definition of a Major Shareholding Notification, which involves notification of changes in significant share ownership levels crossing thresholds. The document length is over 5,000 characters and contains detailed substantive information about shareholding changes, not just an announcement or certification. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2020-04-16 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.